J Clin Aesthet Dermatol. 2021;14(2):14–20. by Azza Farag, MD; Mostafa Hammam, MD; Nada Alnaidany, MD; Eman Badr, mD; Mustafa Elshaib; Aliaa El-Swah, MS; and Wafaa Shehata, MD Drs. Farag, Hammam,
J Clin Aesthet Dermatol. 2021;14(2):E69–E88. by Riekie Smit, MD; Elena Gubanova, MD; Joely Kaufman, MD; Marina Landau, MD; Beatriz Molina, MD; Bill Andriopoulos, PhD; Pascal Maisonobe, MSc; Inna Prygova, MD;
J Clin Aesthet Dermatol. 2021;14(2):61–67. by Eman Elmorsy, PhD; Nouran Aboukhadr, PhD; Maha Tayyeb, MS; and Alsayeda A.A. Taha, PhD All authors are with the Faculty of Medicine at University
J Clin Aesthet Dermatol. 2021;14(2):50–60. by Kelly Segars, DO; Victoria McCarver, DO; and Richard A. Miller, DO Dr. Segars is with the Nova Southeastern University: College of Osteopathic Medicine and
J Clin Aesthet Dermatol. 2021;14(2):46–49. by Jagdish Sakhiya, MD; Dhruv Sakhiya, MBBS Student; Neha Virmani, MBBS, MD, DNB; Trusha Gajjar, DVD; Jitesh Kaklotar, DDV; Ravi Khambhati, MBBS, DVD; Feral Daruwala,
J Clin Aesthet Dermatol. 2021;14(2):44–45. by Cory Pettit, MD, and Joy Mosser-Goldfarb, MD Drs. Pettit and Mosser-Goldfarb are with the Division of Dermatology, Department of Internal Medicine, The Ohio State
J Clin Aesthet Dermatol. 2021;14(2):42–43. by Noureddine Litaiem, MD; Olfa Charfi, MD; Takwa Bacha, MD; and Faten Zeglaoui, MD, PhD All authors are with the Department of Dermatology at Charles
J Clin Aesthet Dermatol. 2021;14(2):34–40. by Soheir Ghonemy, MD; Mohamed Mohamed Mahmoud Nasr, MD; Mohammad Soliman, MD; and Heba Allah Hosiney All authors are with the Dermatology department, Faculty of
J Clin Aesthet Dermatol. 2021;14(2):26–33. by Brianna De Souza, MD; Andrea Tovar-Garza, MD; Laura N. Uwakwe, MD; and Amy McMichael, MD All authors are with the Department of Dermatology
J Clin Aesthet Dermatol. 2021;14(2):22–24. by Rym Afiouni, MD; Josiane Helou, MD; Stephanie Matar, MD; and Roland Tomb, MD, PhD All authors are with the Department of Dermatology, Hôtel-Dieu de
J Clin Aesthet Dermatol. 2021;14(2):12–13. Dear Editor: In their recent article, Lowery et al1 argue that iPLEDGE should remove abstinence as a contraceptive method, requiring individuals with reproductive potential to
J Clin Aesthet Dermatol. 2021;14(2):12–13. Dear Editor: iPLEDGE, the risk evaluation and mitigation strategy program for isotretinoin, has been criticized for being unnecessarily complex, antiquated, and ineffective. It mandates that